Newamsterdam Pharma Co. N.V.

NAMS·NASDAQ·$36.11Share Price as of 11/2·$4BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/18/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/06/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report09/21/26 8-KCurrent report08/14/26 8-K/ACurrent report (amended)08/14/26 8-KCurrent report08/05/26

Prospectuses and Registrations

S-8Registration of securities for employees06/05/26 S-8Registration of securities for employees02/18/26 424B3Prospectus03/10/25 S-3Shelf registration02/28/25 S-8Registration of securities for employees01/07/25

Proxies

DEF 14ADefinitive proxy05/06/26 PRE 14APreliminary proxy04/20/26 DEF 14ADefinitive proxy05/08/25 PRE 14APreliminary proxy04/28/25 DEF 14ADefinitive proxy05/09/24

Ownership

Form 4Insider transaction10/02/26 SC 13D/ABeneficial ownership (amended)09/22/26 Form 4Insider transaction09/15/26 Form 4Insider transaction09/09/26 Form 4Insider transaction09/03/26

Other

ARSAnnual report to shareholders05/06/26 ARSAnnual report to shareholders05/08/25 EFFECTRequest for effectiveness03/10/25 CORRESPCorrespondence with the SEC03/06/25 UPLOADLetter from the SEC03/04/25